Table 2.
Nonsmokers (n=33) | Placebo-treated smokers (n=26) | Vitamin C-treated smokers (n=29) | p-value nonsmoker vs. placebo | p-value nonsmoker vs. vitaminC | p-value vitamin C vs. placebo | |
---|---|---|---|---|---|---|
Umbilical vein Doppler velocity (Vmax), cm/s | 28.00 ± 1.31 | 23.49 ± 1.10 | 27.88 ± 1.21 | 0.05 | 0.92 | 0.04 |
Umbilical vein volume blood flow (cQUV), mL/min | 254.9 ± 14.2 | 209.4 ± 14.6 | 249.2 ± 16.0 | 0.17 | 0.71 | 0.09 |
Umbilical artery pulsatility index (UAPI) | 0.90 ± 0.02 | 0.99 ± 0.03 | 0.99 ± 0.03 | 0.07 | 0.05 | 0.95 |
IAUV—intraabdominal umbilical vein diameter (IAUV), cm | 0.62 ± 0.02 | 0.61 ± 0.02 | 0.61 ± 0.01 | 0.85 | 0.78 | 0.93 |
Cross sectional area of the umbilical vein (CSA), cm2 | 0.31 ± 0.02 | 0.30 ± 0.02 | 0.30 ± 0.01 | 0.83 | 0.75 | 0.94 |
Fetal heart rate (FHR), beats/min | 143.0 ± 1.6 | 137.3 ± 1.9 | 141.3 ± 2.0 | 0.02 | 0.59 | 0.06 |
Data shown as mean ± SE. CSA calculated as π(UV diameter (cm)/2)2; cQUV calculated as 0.5 × Vmax × CSA × 60. P-values for F-test using mixed linear model per measurement adjusted for gestational age at ultrasound and BMI. Logarithmic transformation were performed for the following measurements to reduce skewness of residuals: IAUV, CSA, cQUV, and FHR.